Results 51 to 60 of about 284,282 (314)

Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag−/− Mice

open access: yesFrontiers in Cellular and Infection Microbiology, 2018
Streptococcus pneumoniae causes infection-related mortality worldwide. Immunocompromised individuals, including young children, the elderly, and those with immunodeficiency, are especially vulnerable, yet little is known regarding S.
Krysta M. Felix   +10 more
doaj   +1 more source

Septic shock in the immunocompromised cancer patient: a narrative review

open access: yesCritical Care
Immunosuppressed patients, particularly those with cancer, represent a momentous and increasing portion of the population, especially as cancer incidence rises with population growth and aging. These patients are at a heightened risk of developing severe
J. Nates   +12 more
semanticscholar   +1 more source

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

open access: yesJournal of Infectious Diseases, 2020
We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis demonstrate ongoing replication of infectious severe acute respiratory syndrome ...
Jihoon Baang   +10 more
semanticscholar   +1 more source

Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection

open access: yesJournal of Infectious Diseases, 2021
Guidelines for stopping COVID-19 patient isolation are mainly symptom-based, with isolation for 10 to 20 days depending on their condition. Here, we describe three deeply immunocompromised patients, each with different clinical evolutions.
Hassan Tarhini   +14 more
semanticscholar   +1 more source

Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis

open access: yesJournal of Infection, 2022
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 infection. Methods Systematic review and meta-analysis.
Alexandre R.MD MarraMS   +14 more
semanticscholar   +1 more source

Lymphomas in immunocompromised patients

open access: yesAnnales de Biologie Clinique, 2020
Immunosuppression is a well known risk factor for the development of lymphoid pathologies. The classification of these neoplasias is becoming more precise and complex, some features being common to all immunocompromised patients, primarily the important influence of Epstein-Barr virus.
Florent, Plasse   +8 more
openaire   +3 more sources

Surgical Site Infection Caused by Aeromonas hydrophila in a Patient with Underlying Malignancy [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Aeromonas skin and soft tissue infections in cancer patients can lead to serious life threatening conditions such as cellulitis, necrotizing fasciitis and myonecrosis.
Frincy Khandelwal Baruah   +2 more
doaj   +1 more source

Fungal infections in immunocompromised critically ill patients

open access: yesJournal of Intensive Medicine
Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU.
José Garnacho-Montero   +2 more
semanticscholar   +1 more source

Intralesional bleomycin for treatment of a recalcitrant wart in an immunocompromised patient: A safe, effective, and underutilized therapy

open access: yesClinical Case Reports, 2022
Injectable bleomycin is infrequently used for recalcitrant warts despite its efficacy, acceptable safety profile, and high patient satisfaction compared with other treatment modalities.
Tracy Ngo   +3 more
doaj   +1 more source

Hepatitis E in immunocompromised individuals

open access: yesWorld Journal of Hepatology, 2022
Hepatitis E virus (HEV) originally identified as a cause of acute icteric hepatitis in developing countries has grown to be a cause of zoonotic viral hepatitis in developed countries such as the United States.
Konstantinos Damiris   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy